Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Olson

Concepts (319)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
117
2.750
 Why?
Ophthalmologic Surgical Procedures
5
2017
90
1.940
 Why?
Angiogenesis Inhibitors
11
2022
237
1.840
 Why?
Retina
11
2016
324
1.540
 Why?
Eye Foreign Bodies
5
2016
23
1.480
 Why?
Glaucoma
4
2017
250
1.460
 Why?
Alloys
4
2013
38
1.460
 Why?
Macular Edema
4
2022
49
1.420
 Why?
Retinal Detachment
6
2019
72
1.390
 Why?
Vitrectomy
7
2019
73
1.350
 Why?
Glaucoma Drainage Implants
3
2016
46
1.300
 Why?
Diabetic Retinopathy
6
2019
208
1.290
 Why?
Retinal Diseases
5
2017
101
1.130
 Why?
Intraocular Pressure
7
2017
328
1.120
 Why?
Nanopores
2
2020
10
1.110
 Why?
Intravitreal Injections
7
2022
71
1.070
 Why?
Membranes, Artificial
2
2020
75
1.070
 Why?
Nanotechnology
2
2020
126
1.020
 Why?
Suction
3
2015
33
0.940
 Why?
Sutures
3
2015
64
0.880
 Why?
Anterior Eye Segment
2
2017
10
0.870
 Why?
Choroidal Neovascularization
4
2011
57
0.870
 Why?
Swine
10
2017
833
0.850
 Why?
Suture Techniques
3
2015
131
0.850
 Why?
Equipment Design
6
2017
530
0.830
 Why?
Lens Implantation, Intraocular
2
2015
80
0.800
 Why?
Retinitis
1
2022
21
0.740
 Why?
Retinal Vasculitis
1
2022
12
0.730
 Why?
Aneurysm
1
2022
37
0.720
 Why?
Vitreoretinopathy, Proliferative
2
2019
15
0.680
 Why?
Vascular Endothelial Growth Factor A
6
2020
557
0.670
 Why?
Antibodies, Monoclonal
6
2020
1519
0.650
 Why?
Durapatite
1
2020
36
0.640
 Why?
Retinal Vessels
2
2015
77
0.630
 Why?
Cytomegalovirus Retinitis
2
2013
22
0.620
 Why?
Isoxazoles
2
2013
53
0.620
 Why?
Eye Injuries, Penetrating
3
2016
19
0.620
 Why?
Immunosuppressive Agents
3
2013
846
0.620
 Why?
Scleral Buckling
3
2012
16
0.620
 Why?
Endophthalmitis
2
2017
45
0.610
 Why?
Complement System Proteins
2
2020
316
0.610
 Why?
Disease Models, Animal
8
2020
4557
0.590
 Why?
Stents
2
2013
556
0.560
 Why?
Fluorocarbons
2
2012
143
0.530
 Why?
Glucocorticoids
2
2020
535
0.520
 Why?
Anterior Chamber
1
2017
27
0.520
 Why?
Transducers
1
2017
26
0.510
 Why?
Sclera
2
2015
38
0.490
 Why?
Strabismus
1
2017
71
0.490
 Why?
Filtering Surgery
1
2016
23
0.490
 Why?
Surgical Instruments
2
2013
51
0.480
 Why?
Trabeculectomy
1
2017
75
0.480
 Why?
Fovea Centralis
2
2006
24
0.460
 Why?
Retinal Perforations
2
2005
18
0.460
 Why?
Drug Resistance, Multiple, Viral
2
2013
10
0.460
 Why?
Ocular Hypertension
1
2016
70
0.460
 Why?
Lenses, Intraocular
1
2015
49
0.450
 Why?
Monitoring, Physiologic
1
2017
289
0.440
 Why?
Laser Therapy
1
2017
135
0.440
 Why?
Ophthalmology
2
2013
116
0.440
 Why?
Lasers
1
2015
132
0.440
 Why?
Prostheses and Implants
1
2016
141
0.430
 Why?
Device Removal
1
2016
143
0.430
 Why?
Ischemia
2
2017
421
0.410
 Why?
Antiviral Agents
2
2013
767
0.410
 Why?
Rabbits
3
2020
648
0.410
 Why?
Tomography, Optical Coherence
7
2015
271
0.410
 Why?
Models, Cardiovascular
1
2015
195
0.400
 Why?
Fluorescein Angiography
9
2012
189
0.390
 Why?
Retinal Degeneration
2
2015
40
0.390
 Why?
Artificial Lens Implant Migration
1
2013
3
0.390
 Why?
Viscosupplements
1
2012
11
0.380
 Why?
Gravitation
1
2012
20
0.380
 Why?
Choroid
3
2015
80
0.380
 Why?
Animals
18
2020
38058
0.380
 Why?
Silicon
1
2012
22
0.370
 Why?
Macular Degeneration
6
2015
191
0.370
 Why?
Pupil Disorders
1
2012
7
0.370
 Why?
Eye Enucleation
1
2012
14
0.370
 Why?
Iris
1
2012
24
0.370
 Why?
Silicone Oils
1
2012
34
0.370
 Why?
Quantum Dots
1
2012
39
0.370
 Why?
Silicone Elastomers
1
2012
7
0.370
 Why?
Viremia
1
2013
158
0.360
 Why?
Uveitis, Posterior
1
2012
12
0.360
 Why?
Prosthesis Implantation
1
2013
153
0.360
 Why?
Surgical Stapling
1
2012
16
0.360
 Why?
Electric Stimulation Therapy
1
2012
62
0.360
 Why?
Fluocinolone Acetonide
1
2012
15
0.360
 Why?
Vitreous Hemorrhage
2
2015
10
0.350
 Why?
Cataract Extraction
1
2013
119
0.340
 Why?
Vascular Endothelial Growth Factors
1
2011
80
0.340
 Why?
Models, Biological
4
2015
1821
0.330
 Why?
Materials Testing
1
2012
354
0.320
 Why?
Cytomegalovirus
2
2013
168
0.310
 Why?
Oxygen
1
2015
995
0.300
 Why?
Humans
47
2022
144759
0.290
 Why?
Anti-Inflammatory Agents
1
2012
474
0.280
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
253
0.270
 Why?
Biocompatible Materials
1
2012
435
0.260
 Why?
Electroretinography
5
2016
50
0.260
 Why?
von Hippel-Lindau Disease
1
2007
12
0.260
 Why?
Pigment Epithelium of Eye
2
2006
36
0.250
 Why?
Injections
5
2012
196
0.250
 Why?
Puerperal Disorders
1
2007
37
0.250
 Why?
Drug Implants
2
2020
83
0.250
 Why?
Recombinant Fusion Proteins
4
2022
675
0.250
 Why?
Uveal Diseases
1
2006
6
0.240
 Why?
Ocular Hypotension
1
2006
10
0.240
 Why?
Fusobacterium Infections
1
2006
7
0.240
 Why?
Pharyngeal Diseases
1
2006
16
0.240
 Why?
Needles
2
2017
62
0.240
 Why?
Epiretinal Membrane
1
2005
7
0.240
 Why?
Ciliary Body
1
2006
40
0.230
 Why?
Telangiectasis
1
2005
7
0.230
 Why?
Rats, Inbred BN
3
2011
55
0.230
 Why?
Antibodies, Monoclonal, Humanized
6
2015
985
0.220
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2022
109
0.220
 Why?
Uveitis
1
2006
148
0.220
 Why?
Visual Acuity
7
2019
489
0.220
 Why?
Dementia
2
2022
303
0.220
 Why?
Injections, Intraocular
2
2015
14
0.210
 Why?
Kidney Transplantation
2
2013
704
0.210
 Why?
Polypropylenes
2
2015
12
0.210
 Why?
Female
26
2022
78271
0.210
 Why?
Optic Atrophy
1
2022
8
0.190
 Why?
Hearing Loss, Central
1
2022
6
0.190
 Why?
Bevacizumab
6
2015
167
0.190
 Why?
Laser Coagulation
3
2012
77
0.180
 Why?
Middle Aged
17
2019
35875
0.180
 Why?
Autoimmune Diseases
1
2006
463
0.180
 Why?
Retinal Vein Occlusion
2
2015
14
0.170
 Why?
Cell Count
2
2012
320
0.170
 Why?
Rats
4
2012
5597
0.170
 Why?
Dialysis
1
2020
18
0.160
 Why?
Leukemia, Megakaryoblastic, Acute
1
2000
10
0.160
 Why?
Orbital Neoplasms
1
2000
27
0.160
 Why?
Adsorption
1
2020
157
0.160
 Why?
Time Factors
4
2017
7173
0.150
 Why?
Follow-Up Studies
5
2015
5408
0.150
 Why?
Male
21
2019
72315
0.140
 Why?
Biomarkers
2
2020
4271
0.140
 Why?
Eye Diseases, Hereditary
1
2018
15
0.140
 Why?
Fluorescein-5-isothiocyanate
2
2009
36
0.140
 Why?
Adult
11
2022
40449
0.140
 Why?
Wet Macular Degeneration
1
2019
58
0.140
 Why?
Miniaturization
2
2015
22
0.140
 Why?
Dextrans
2
2009
86
0.140
 Why?
Geographic Atrophy
1
2019
97
0.130
 Why?
Iris Diseases
1
2017
7
0.130
 Why?
Enzyme-Linked Immunosorbent Assay
1
2019
851
0.130
 Why?
Choroid Diseases
1
2017
10
0.130
 Why?
Glomerulonephritis, Membranoproliferative
1
1997
25
0.130
 Why?
Hypertension
1
2006
1263
0.130
 Why?
Dark Adaptation
2
2012
13
0.130
 Why?
Antimony
1
2016
4
0.130
 Why?
Infliximab
2
2007
108
0.120
 Why?
Dose-Response Relationship, Drug
3
2014
2027
0.120
 Why?
Pressure
1
2017
225
0.120
 Why?
Polymers
1
2020
499
0.120
 Why?
Sclerostomy
1
2015
4
0.120
 Why?
Foreign-Body Migration
1
2016
32
0.120
 Why?
Gyrate Atrophy
1
2015
2
0.110
 Why?
Aged, 80 and over
6
2019
8265
0.110
 Why?
Vitreoretinal Surgery
1
2015
4
0.110
 Why?
Equipment Failure Analysis
1
2015
128
0.110
 Why?
Vitreous Detachment
1
2015
6
0.110
 Why?
Partial Pressure
1
2015
31
0.110
 Why?
Hemoglobin SC Disease
1
2015
14
0.110
 Why?
Diagnostic Techniques, Ophthalmological
1
2015
53
0.110
 Why?
Stress, Mechanical
1
2017
494
0.110
 Why?
Eye Infections, Bacterial
1
2015
44
0.110
 Why?
Biopsy, Needle
1
2015
183
0.110
 Why?
Prosthesis Failure
1
2016
127
0.110
 Why?
Treatment Outcome
9
2016
11679
0.110
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1414
0.110
 Why?
Feedback
1
2015
181
0.110
 Why?
International Normalized Ratio
1
2014
49
0.110
 Why?
Aged
10
2020
25913
0.110
 Why?
Oculomotor Muscles
1
2014
84
0.100
 Why?
Protein Binding
1
2020
2273
0.100
 Why?
In Vitro Techniques
1
2015
1047
0.100
 Why?
Exchange Transfusion, Whole Blood
1
2013
19
0.100
 Why?
Retinal Artery Occlusion
1
2013
10
0.100
 Why?
Tendons
1
2014
129
0.100
 Why?
Postoperative Care
1
2015
288
0.100
 Why?
Warfarin
1
2014
170
0.100
 Why?
Down Syndrome
1
2000
534
0.100
 Why?
Specific Gravity
1
2012
11
0.100
 Why?
Transducers, Pressure
1
2012
12
0.100
 Why?
Adaptation, Ocular
1
2012
6
0.090
 Why?
Rats, Mutant Strains
1
2012
20
0.090
 Why?
Diabetes Mellitus, Type 2
2
2012
2583
0.090
 Why?
Viscosity
1
2012
90
0.090
 Why?
Research Design
1
2019
1135
0.090
 Why?
Minerals
1
2012
47
0.090
 Why?
Erythrocyte Transfusion
1
2015
231
0.090
 Why?
Pupil
1
2012
22
0.090
 Why?
Acetates
1
2012
80
0.090
 Why?
Metabolomics
1
2018
727
0.090
 Why?
Antineoplastic Agents
2
2020
2194
0.090
 Why?
Corneal Endothelial Cell Loss
1
2012
3
0.090
 Why?
Endothelium, Corneal
1
2012
19
0.090
 Why?
Sodium Chloride
1
2012
141
0.090
 Why?
Retinal Neovascularization
1
2012
29
0.090
 Why?
Tumor Necrosis Factor-alpha
2
2007
1217
0.090
 Why?
Microsurgery
1
2012
72
0.090
 Why?
Electrodes, Implanted
1
2012
115
0.090
 Why?
Swine, Miniature
1
2012
89
0.090
 Why?
Gold
1
2012
115
0.090
 Why?
Bruch Membrane
1
2011
6
0.090
 Why?
Drug Combinations
1
2012
390
0.090
 Why?
Retinal Ganglion Cells
1
2012
121
0.090
 Why?
Polyglycolic Acid
1
2011
44
0.090
 Why?
Adolescent
4
2019
22428
0.080
 Why?
Administration, Oral
1
2013
847
0.080
 Why?
Drug Compounding
1
2011
107
0.080
 Why?
Dissection
1
2011
56
0.080
 Why?
Delayed-Action Preparations
1
2011
183
0.080
 Why?
Computer Simulation
1
2015
1025
0.080
 Why?
Models, Animal
1
2012
392
0.080
 Why?
Registries
1
2019
2385
0.080
 Why?
Lactic Acid
1
2011
302
0.080
 Why?
Anemia, Sickle Cell
1
2013
312
0.070
 Why?
Cell Survival
1
2012
1098
0.070
 Why?
Retrospective Studies
8
2015
17066
0.070
 Why?
Bacteria
1
2015
889
0.070
 Why?
Scotoma
1
2008
6
0.070
 Why?
Atrial Fibrillation
1
2014
550
0.070
 Why?
Proliferating Cell Nuclear Antigen
1
2007
49
0.070
 Why?
Optic Neuropathy, Ischemic
1
2007
31
0.060
 Why?
Papilledema
1
2007
44
0.060
 Why?
Severity of Illness Index
2
2014
2925
0.060
 Why?
Visual Fields
3
2007
115
0.060
 Why?
RNA, Catalytic
1
2007
189
0.060
 Why?
Retinitis Pigmentosa
1
2006
20
0.060
 Why?
Glycogen Storage Disease Type IIb
1
2006
27
0.060
 Why?
Triamcinolone Acetonide
1
2006
20
0.060
 Why?
Fusobacterium necrophorum
1
2006
2
0.060
 Why?
Pilot Projects
1
2012
1886
0.060
 Why?
Polyethylene Glycols
1
2011
654
0.060
 Why?
Vision, Low
3
2013
17
0.060
 Why?
Indocyanine Green
1
2005
42
0.060
 Why?
Myopia
1
2006
59
0.060
 Why?
Coloring Agents
1
2005
93
0.060
 Why?
Eye Injuries
1
2006
53
0.060
 Why?
Infusions, Intravenous
1
2006
423
0.060
 Why?
Staining and Labeling
1
2005
151
0.060
 Why?
Syndrome
1
2006
380
0.050
 Why?
Young Adult
2
2019
14105
0.050
 Why?
Cataract
1
2006
238
0.050
 Why?
Multivariate Analysis
2
2019
1539
0.050
 Why?
Diagnosis, Differential
1
2007
1489
0.050
 Why?
Ranibizumab
2
2013
21
0.040
 Why?
Blindness
2
2013
52
0.040
 Why?
Exophthalmos
1
2000
17
0.040
 Why?
Keratitis
1
2000
20
0.040
 Why?
Chronic Disease
1
2006
1813
0.040
 Why?
Postoperative Complications
1
2012
2919
0.040
 Why?
Immunophenotyping
1
2000
322
0.040
 Why?
Xanthine
1
2018
7
0.040
 Why?
Tomography, X-Ray Computed
2
2016
2730
0.030
 Why?
Combined Modality Therapy
2
2013
1266
0.030
 Why?
Electrooculography
1
1997
12
0.030
 Why?
Color Vision Defects
1
1997
8
0.030
 Why?
Visual Field Tests
1
1997
32
0.030
 Why?
Purines
1
2018
187
0.030
 Why?
Fundus Oculi
1
1997
89
0.030
 Why?
Odds Ratio
1
2019
1075
0.030
 Why?
Cohort Studies
2
2019
5960
0.030
 Why?
Photic Stimulation
1
1997
264
0.030
 Why?
Child
2
2015
22633
0.030
 Why?
Microbiological Techniques
1
2015
33
0.030
 Why?
Colony Count, Microbial
1
2015
122
0.030
 Why?
Endotamponade
1
2015
2
0.030
 Why?
Vision Disorders
1
1997
178
0.030
 Why?
Myopia, Degenerative
1
2015
5
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
34
0.030
 Why?
Mass Spectrometry
1
2018
750
0.030
 Why?
Photography
1
2015
115
0.030
 Why?
Metabolome
1
2018
384
0.030
 Why?
Conjunctiva
1
2014
53
0.030
 Why?
Biometry
1
2014
68
0.030
 Why?
Atrophy
1
2015
201
0.030
 Why?
Disease Progression
2
2015
2847
0.030
 Why?
Pregnancy
1
2007
7190
0.030
 Why?
Glucose
1
2018
1047
0.020
 Why?
Fatty Acids, Omega-3
1
2014
142
0.020
 Why?
Risk Factors
2
2019
10779
0.020
 Why?
Retreatment
1
2012
77
0.020
 Why?
Kaplan-Meier Estimate
1
2014
965
0.020
 Why?
Risk Assessment
2
2014
3671
0.020
 Why?
Oxidative Stress
1
2018
1339
0.020
 Why?
Survival Analysis
1
2014
1382
0.020
 Why?
Proportional Hazards Models
1
2014
1325
0.020
 Why?
Global Health
1
2014
401
0.020
 Why?
Phenotype
1
2019
3162
0.020
 Why?
Health Care Costs
1
2014
427
0.020
 Why?
Antioxidants
1
2014
549
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
439
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2009
77
0.020
 Why?
Clinical Trials, Phase I as Topic
1
2009
52
0.020
 Why?
Comorbidity
1
2014
1658
0.020
 Why?
Anticoagulants
1
2014
722
0.020
 Why?
Colorado
1
2019
4564
0.020
 Why?
Retinal Artery
1
2007
17
0.020
 Why?
Prospective Studies
2
2012
7990
0.020
 Why?
Cerebral Angiography
1
2007
119
0.020
 Why?
Lysosomal-Associated Membrane Protein 2
1
2006
32
0.020
 Why?
Frameshift Mutation
1
2006
32
0.020
 Why?
Secondary Prevention
1
2007
254
0.010
 Why?
Infant
1
2000
10034
0.010
 Why?
Prognosis
1
2014
4282
0.010
 Why?
Adrenal Cortex Hormones
1
2008
478
0.010
 Why?
Anti-Bacterial Agents
1
2015
1907
0.010
 Why?
Double-Blind Method
1
2007
2029
0.010
 Why?
RNA, Messenger
1
2007
2832
0.010
 Why?
Aging
1
2008
1966
0.010
 Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (319) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)